Written Question · S2W-25925 · Session 2
What literature or guidance it provides to patients to ensure that they know how to report an adverse drug reaction.
The question
To ask the Scottish Executive what literature or guidance it provides to patients to ensure that they know how to report an adverse drug reaction.
The answer
The regulation and safety ofmedicines are reserved and are the responsibility of the Medicines andHealthcare products Regulatory Agency (MHRA). The MHRA and the Commission onHuman Medicines run the UK’s spontaneous adverse drug reaction reporting scheme,the Yellow Card Scheme.
Patients, parents and carerscan report suspected adverse reactions through the Yellow Card Scheme. The MHRAsupplied Yellow Cards for patients to a number of National Health Serviceoutlets including all General Practitioners, community and hospital pharmaciesin autumn 2005. The Yellow Cards provide guidance notes on when and how toreport suspected adverse reactions. Posters were also sent to all outlets withdetails of how to report. The MHRA leaflet Taking medicines
- some questionsand answers about side effects also includes information on how to report asuspected adverse reaction. This was launched in December 2005 and the MHRA isworking with the Commission on Human Medicines’ Patient Information ExpertAdvisory Group to discuss how this leaflet and the patient Yellow Card can befurther promoted and made available. The MHRA is also developing acommunication campaign, which includes articles in magazines, and working withvoluntary organisations to promote patient reporting of suspected adversereactions.
Patients, parents and carerscan report suspected adverse reactions through the Yellow Card Scheme. The MHRAsupplied Yellow Cards for patients to a number of National Health Serviceoutlets including all General Practitioners, community and hospital pharmaciesin autumn 2005. The Yellow Cards provide guidance notes on when and how toreport suspected adverse reactions. Posters were also sent to all outlets withdetails of how to report. The MHRA leaflet Taking medicines
- some questionsand answers about side effects also includes information on how to report asuspected adverse reaction. This was launched in December 2005 and the MHRA isworking with the Commission on Human Medicines’ Patient Information ExpertAdvisory Group to discuss how this leaflet and the patient Yellow Card can befurther promoted and made available. The MHRA is also developing acommunication campaign, which includes articles in magazines, and working withvoluntary organisations to promote patient reporting of suspected adversereactions.
In the Official Report
No contribution in the Official Report cites S2W-25925 by reference.